U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of
1934, Section 17(a) of the Public Utility Holding Company Act of
1935 or Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person*
SHUEY III ROBERT A.
(Last) (First) (Middle)
8214 WESTCHESTER SUITE 500
(Street)
DALLAS TX 75225
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/96
3. IRS Identification Number of Reporting Person, if an entity
(voluntary)
4. Issuer Name and Ticker or Trading Symbol
EUROMED INC "EMED"
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
/X / Director /X / 10% Owner
/x/ Officer (give title below) / / Other (specify below)
CHIEF EXECUTIVE OFFICER
6. If Amendment, Date of Original
(Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
/x/ Form filed by One Reporting Person
/ / Form filed by More than One Reporting Person
TABLE I - Non-Derivative Securities Beneficially Owned
<TABLE>
<CAPTION>
<S> <C> <C> <C>
1. Title of 2. Amount 3. Ownership 4. Nature of Indirect
Security of Form: Beneficial Ownership
(Instr.4) Securities Direct (D) or (Instr. 5)
Beneficially Indirect
Owned (I)
(Instr. 4) (Instr. 5)
- - -------------------------------------------------------------------------------
COMMON STOCK 342,500 (D)
- - --------------------------------------------------------------------------------
- - --------------------------------------------------------------------------------
- - --------------------------------------------------------------------------------
- - --------------------------------------------------------------------------------
- - --------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 5(b)(v)
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB control number.
(over)
SEC 1474 (7-97)
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
FORM 3 (continued)
TABLE II - Derivative Securities Benefically Owned
(e.g., puts, calls, warrants, options, convertible securities)
<S> <C> <C> <C> <C> <C>
1. Title of 2. Date 3. Title and 4. Conversion 5. Ownership 6. Nature of Indirect
Derivative Exercisable Amount of or Exercise Form of Beneficial Ownership
Security and Securities Price of Derivative (Instr. 5)
(Instr.4) Expiration Underlying Derivative Security:
Date Security (Instr. 4) Security Direct (D) or
(Month/Day/Year) Indirect (I)
(Instr. 5)
Date Expira- Title Amount or
Exer- tion Number of
cisable Date Shares
- - ----------------------------------------------------------------------------------------------------------------------------------
WARRANTS 12/29/97 12/29/02 Class A Common Stock 100,000 $0.30 (D)
-----------------------------------------------------------------------------------------------------------------------------------
- - ---------------------------------------------------------------------------------------------------------------------------------
- - ---------------------------------------------------------------------------------------------------------------------------------
- - ---------------------------------------------------------------------------------------------------------------------------------
- - ---------------------------------------------------------------------------------------------------------------------------------
</TABLE>
(1) Warrants to buy 100,000 shares of EuroMed Common Stock at a purchase price
of $0.30, granted for services rendered.
Explanation of Responses:
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15
U.S.C. 78ff(a).
/s/ ROBERT A. SHUEY III 04/13/99
**Signature of Reporting Person Date
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
Page 2
SEC 1474 (7-97)
